Esperion Therapeutics

ESPR:NASDAQ

Last:
Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

Esperion is the Lipid Management Company committed to developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies for the treatment of patients with elevated LDL-C.